Ter Meulen Jan Henrik

Avg. Two Year Performance

No purchase track record
20% Avg. Sale Return
9% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return9%4%(31%)35%20%
Sale Success Rate2 of 31 of 30 of 32 of 31 of 3
Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--